Clinical trials
Completed Observational Gastrointestinal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 7 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 69 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Exact Sciences Corporation | 5 |
| Ankara Etlik City Hospital | 3 |
| Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | 3 |
| Mayo Clinic | 3 |
| Baylor College of Medicine | 2 |
| Bristol-Myers Squibb | 2 |
| Hospices Civils de Lyon | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| Ankara Oncology Research and Training Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Neoplasms | 69 |
| Colorectal Neoplasms | 18 |
| Neoplasms | 13 |
| Gastrointestinal Diseases | 9 |
| Lung Neoplasms | 9 |
| Rectal Diseases | 9 |
| Colonic Diseases | 8 |
| Digestive System Diseases | 8 |
| Digestive System Neoplasms | 8 |
| Intestinal Diseases | 8 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.